Using the influenza vaccine as a mild, exogenous inflammatory challenge: When does inflammation peak?

BACKGROUND: The influenza vaccine has shown promise as a mild, exogenous inflammatory challenge, but use of this model is limited by lack of knowledge about the timing of the inflammatory response. This study was designed to characterize the time-course of the acute inflammatory response and explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Radin, Arielle S., Kuhlman, Kate R., Boyle, Chloe C., Haydon, Marcie D., Bower, Julienne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474380/
https://www.ncbi.nlm.nih.gov/pubmed/34589752
http://dx.doi.org/10.1016/j.bbih.2021.100239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474380/
https://www.ncbi.nlm.nih.gov/pubmed/34589752
http://dx.doi.org/10.1016/j.bbih.2021.100239

Ejemplares similares